Tobe SW, Mavrakanas TA, Bajaj HS, Levin A, et al. Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE trials. Diabetes Care 2024 Jan 22:dc231450. doi: 10.2337/dc23-1450.
PMID: 38252809